
Waymond D. Bray
Examiner (ID: 831)
| Most Active Art Unit | 3201 |
| Art Unit(s) | 3725, 2899, 3204, 3201, 3203 |
| Total Applications | 3197 |
| Issued Applications | 3049 |
| Pending Applications | 43 |
| Abandoned Applications | 104 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7281277
[patent_doc_number] => 20040063654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Methods and compositions for therapeutic use of RNA interference'
[patent_app_type] => new
[patent_app_number] => 10/440506
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24879
[patent_no_of_claims] => 231
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063654.pdf
[firstpage_image] =>[orig_patent_app_number] => 10440506
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/440506 | Methods and compositions for therapeutic use of RNA interference | May 14, 2003 | Abandoned |
Array
(
[id] => 6830354
[patent_doc_number] => 20030181412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses'
[patent_app_type] => new
[patent_app_number] => 10/438151
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 22409
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181412.pdf
[firstpage_image] =>[orig_patent_app_number] => 10438151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/438151 | Method for modifying transcription and/or translation in an organism for therapeutic, prophylactic and/or analytic uses | May 13, 2003 | Abandoned |
Array
(
[id] => 7673341
[patent_doc_number] => 20040180438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Methods and compositions for silencing genes without inducing toxicity'
[patent_app_type] => new
[patent_app_number] => 10/425006
[patent_app_country] => US
[patent_app_date] => 2003-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 34069
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180438.pdf
[firstpage_image] =>[orig_patent_app_number] => 10425006
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/425006 | Methods and compositions for silencing genes without inducing toxicity | Apr 27, 2003 | Abandoned |
Array
(
[id] => 7444237
[patent_doc_number] => 20040009510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Allosteric nucleic acid sensor molecules'
[patent_app_type] => new
[patent_app_number] => 10/422050
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 47542
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009510.pdf
[firstpage_image] =>[orig_patent_app_number] => 10422050
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/422050 | Allosteric nucleic acid sensor molecules | Apr 22, 2003 | Abandoned |
Array
(
[id] => 7367395
[patent_doc_number] => 20040006036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Silencing transcription by methylation'
[patent_app_type] => new
[patent_app_number] => 10/422466
[patent_app_country] => US
[patent_app_date] => 2003-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15884
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0006/20040006036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10422466
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/422466 | Silencing transcription by methylation | Apr 21, 2003 | Abandoned |
Array
(
[id] => 7463683
[patent_doc_number] => 20040053289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Short interfering nucleic acid hybrids and methods thereof'
[patent_app_type] => new
[patent_app_number] => 10/410220
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7824
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10410220
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/410220 | Short interfering nucleic acid hybrids and methods thereof | Apr 7, 2003 | Abandoned |
Array
(
[id] => 6678462
[patent_doc_number] => 20030228603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Compositions selective for caffeine or aspartame and methods of using same'
[patent_app_type] => new
[patent_app_number] => 10/406903
[patent_app_country] => US
[patent_app_date] => 2003-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 45168
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228603.pdf
[firstpage_image] =>[orig_patent_app_number] => 10406903
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/406903 | Compositions selective for caffeine or aspartame and methods of using same | Apr 2, 2003 | Abandoned |
Array
(
[id] => 7398978
[patent_doc_number] => 20040023265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Methods and compositions for nucleic acid ligands against Shiga toxin and/or Shiga-like toxin'
[patent_app_type] => new
[patent_app_number] => 10/386778
[patent_app_country] => US
[patent_app_date] => 2003-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13802
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023265.pdf
[firstpage_image] =>[orig_patent_app_number] => 10386778
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/386778 | Methods and compositions for nucleic acid ligands against Shiga toxin and/or Shiga-like toxin | Mar 10, 2003 | Abandoned |
Array
(
[id] => 7364441
[patent_doc_number] => 20040005593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Novel method for delivery and intracellular synthesis of siRNA molecules'
[patent_app_type] => new
[patent_app_number] => 10/383835
[patent_app_country] => US
[patent_app_date] => 2003-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7327
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005593.pdf
[firstpage_image] =>[orig_patent_app_number] => 10383835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/383835 | Novel method for delivery and intracellular synthesis of siRNA molecules | Mar 5, 2003 | Abandoned |
Array
(
[id] => 7363879
[patent_doc_number] => 20040005546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Use of ribozymes in the detection of adventitious agents'
[patent_app_type] => new
[patent_app_number] => 10/375700
[patent_app_country] => US
[patent_app_date] => 2003-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7778
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005546.pdf
[firstpage_image] =>[orig_patent_app_number] => 10375700
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/375700 | Use of ribozymes in the detection of adventitious agents | Feb 25, 2003 | Abandoned |
Array
(
[id] => 7105093
[patent_doc_number] => 20050107316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent'
[patent_app_type] => utility
[patent_app_number] => 10/505482
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 27137
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107316.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505482 | Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent | Feb 20, 2003 | Abandoned |
Array
(
[id] => 7169504
[patent_doc_number] => 20050202428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Pluripotential stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/504173
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19166
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202428.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504173
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504173 | Pluripotential stem cells | Feb 11, 2003 | Abandoned |
Array
(
[id] => 7363473
[patent_doc_number] => 20040014956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Double-stranded oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/357529
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 25633
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10357529
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/357529 | Double-stranded oligonucleotides | Feb 2, 2003 | Abandoned |
Array
(
[id] => 7287161
[patent_doc_number] => 20040147027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Complex for facilitating delivery of dsRNA into a cell and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/353902
[patent_app_country] => US
[patent_app_date] => 2003-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8738
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147027.pdf
[firstpage_image] =>[orig_patent_app_number] => 10353902
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/353902 | Complex for facilitating delivery of dsRNA into a cell and uses thereof | Jan 27, 2003 | Abandoned |
Array
(
[id] => 7393836
[patent_doc_number] => 20040038322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Potentiation of cancer therapies by ZNF217 inhibition'
[patent_app_type] => new
[patent_app_number] => 10/349627
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 40064
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038322.pdf
[firstpage_image] =>[orig_patent_app_number] => 10349627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/349627 | Potentiation of cancer therapies by ZNF217 inhibition | Jan 21, 2003 | Abandoned |
Array
(
[id] => 6834727
[patent_doc_number] => 20030162273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Modulation of sulfate permease for photosynthetic hydrogen production'
[patent_app_type] => new
[patent_app_number] => 10/350298
[patent_app_country] => US
[patent_app_date] => 2003-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 20444
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10350298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/350298 | Modulation of sulfate permease for photosynthetic hydrogen production | Jan 21, 2003 | Abandoned |
Array
(
[id] => 6856723
[patent_doc_number] => 20030130224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene'
[patent_app_type] => new
[patent_app_number] => 10/339934
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13583
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130224.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339934
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339934 | Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene | Jan 9, 2003 | Abandoned |
Array
(
[id] => 6856723
[patent_doc_number] => 20030130224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene'
[patent_app_type] => new
[patent_app_number] => 10/339934
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13583
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130224.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339934
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339934 | Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene | Jan 9, 2003 | Abandoned |
Array
(
[id] => 7322274
[patent_doc_number] => 20040136960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Devices and processes for distribution of genetic material to mammalian limb'
[patent_app_type] => new
[patent_app_number] => 10/339935
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11716
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20040136960.pdf
[firstpage_image] =>[orig_patent_app_number] => 10339935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/339935 | Devices and processes for distribution of genetic material to mammalian limb | Jan 9, 2003 | Abandoned |
Array
(
[id] => 7398672
[patent_doc_number] => 20040023239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Method of rna cleavage'
[patent_app_type] => new
[patent_app_number] => 10/296574
[patent_app_country] => US
[patent_app_date] => 2003-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8516
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10296574
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/296574 | Method of rna cleavage | Jan 6, 2003 | Abandoned |